EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCHYG00000000570
Gene Symbol: MIF
1 Cross references
220 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCHYG00000024070
Gene Symbol: MST1R
1 Cross references
268 Possible Orthologues:

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSCHYG00000022362
Gene Symbol: MGAM2
1 Cross references
393 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCHYG00000000723
Gene Symbol: MMP1
1 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSCHYG00000000688
Gene Symbol: MMP12
1 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSCHYG00000000652
Gene Symbol: MMP13
1 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSCHYG00000018620
Gene Symbol: MMP14
1 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCHYG00000006606
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSCHYG00000000701
Gene Symbol: MMP3
1 Cross references
502 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSCHYG00000000857
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSCHYG00000000770
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCHYG00000021252
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).